Scientists test 'Trackable' immune cells in fight against stubborn lymphoma
NCT ID NCT07343934
Summary
This is an early safety study testing a new type of modified immune cell therapy for adults whose follicular lymphoma has returned or not responded to prior treatments. The main goals are to see if the treatment is safe to give and if researchers can successfully track where these specially engineered cells go in the body using a new imaging technique. The study will involve a small group of 6 participants to gather initial data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.